Current Opinion and Knowledge on Peritoneal Carcinomatosis: A Survey among a Swiss Oncology Network.

Details

Serval ID
serval:BIB_4174AA4D6600
Type
Article: article from journal or magazin.
Collection
Publications
Title
Current Opinion and Knowledge on Peritoneal Carcinomatosis: A Survey among a Swiss Oncology Network.
Journal
Chemotherapy
Author(s)
Grass F., Martin D., Montemurro M., Mathevet P., Wolfer A., Coukos G., Demartines N., Hübner M.
ISSN
1421-9794 (Electronic)
ISSN-L
0009-3157
Publication state
Published
Issued date
2018
Peer-reviewed
Oui
Volume
63
Number
3
Pages
143-147
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
The present survey aimed to evaluate current opinion and practice regarding peritoneal metastasis (PM), satisfaction with available treatment options, and need for new therapeutic approaches.
This was a qualitative study conducted between October 2016 and October 2017 in the Réseau Suisse Romand d'Oncologie including 101 members of various oncological specialties. Participants' demographics, current practice, knowledge, and satisfaction regarding available treatment options and need for new treatment options were assessed by semantic differential scales through 33 closed questions with automatic reminders at 4-, 8-, 12-, and 16-week intervals.
Twenty-seven participants (27%) completed the survey. Participants were gastrointestinal or gynecologic oncologists and surgeons. Most participants (67%) evaluated their knowledge on PM as moderate, while 22% considered themselves as experts. Clinical usefulness of systemic chemotherapy and hyperthermic intraperitoneal chemotherapy was judged to be moderate to high for PM of ovarian and colorectal origin and moderate to poor for gastric origin. Satisfaction with available treatment options was 6/10 (interquartile range [IQR] 4-7) for ovarian, 5/10 (IQR 3-7) for colorectal, and 3/10 (IQR 1-3) for gastric PM. Treatment strategies varied widely for typical case vignettes. The need for new treatment modalities was rated as 8/10 (IQR 6-10).
Usefulness of and satisfaction with available treatment options for PM were rated as moderate at best by oncological experts, and treatment strategies differed importantly among participants. There appears to be a clear need for standardization and new treatment modalities.
Keywords
Antineoplastic Agents/therapeutic use, Carcinoma/diagnosis, Carcinoma/drug therapy, Carcinoma/secondary, Colorectal Neoplasms/pathology, Combined Modality Therapy, Female, Humans, Male, Oncologists/psychology, Ovarian Neoplasms/pathology, Peritoneal Neoplasms/diagnosis, Peritoneal Neoplasms/drug therapy, Peritoneal Neoplasms/secondary, Stomach Neoplasms/pathology, Surveys and Questionnaires, Carcinomatosis, Opinion, Ovarian cancer, Peritoneal metastasis, Satisfaction, Treatment
Pubmed
Web of science
Create date
25/06/2018 9:36
Last modification date
20/08/2019 14:42
Usage data